Rayence Co Ltd
KOSDAQ:228850
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Rayence Co Ltd
Net Income (Common)
Rayence Co Ltd
Net Income (Common) Peer Comparison
145720
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Rayence Co Ltd
KOSDAQ:228850
|
Net Income (Common)
₩21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Dentium Co Ltd
KRX:145720
|
Net Income (Common)
₩94.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Net Income (Common)
₩27.1B
|
CAGR 3-Years
782%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Net Income (Common)
₩81.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Net Income (Common)
₩28.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
Net Income (Common)
₩165.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
38%
|
See Also
What is Rayence Co Ltd's Net Income (Common)?
Net Income (Common)
21B
KRW
Based on the financial report for Mar 31, 2024, Rayence Co Ltd's Net Income (Common) amounts to 21B KRW.
What is Rayence Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
5%
Over the last year, the Net Income (Common) growth was 5%.
You don't have any saved screeners yet
